Patents by Inventor Fiamma Buttitta

Fiamma Buttitta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleotide and deduced amino acid sequences of tumor gene Int6
    Patent number: 7067635
    Abstract: The present invention discloses the isolation of the human and murine wild-type Int6 gene and the cDNAs sorresponding to these genes. The invention further describes the use of reagents derived from the nucleic acid and amino acid sequences of the Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines.
    Type: Grant
    Filed: February 19, 2004
    Date of Patent: June 27, 2006
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Antonio Marchetti, Fiamma Buttitta, Gilbert H. Smith, Robert Callahan
  • Nucleotide and deduced amino acid sequences of tumor gene Int6
    Publication number: 20040141918
    Abstract: The present invention discloses the isolation of the human and murine wild-type Int6 gene and the cDNAs sorresponding to these genes. The invention further describes the use of reagents derived from the nucleic acid and amino acid sequences of the Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines.
    Type: Application
    Filed: February 19, 2004
    Publication date: July 22, 2004
    Applicant: The Government of the USA as represented by the Secretary, Department of Health and Human Services
    Inventors: Antonio Marchetti, Fiamma Buttitta, Gilbert H. Smith, Robert Callahan
  • Nucleotide and deduced amino acid sequences of tumor gene Int6
    Patent number: 6737251
    Abstract: The present invention discloses the isolation of the human and murine wild-type Int6 gene and the cDNAs corresponding to these genes. The invention further describes the use of reagents derived from the nucleic acid and amino acid sequences of the Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines.
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: May 18, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Antonio Marchetti, Fiamma Buttitta, Gilbert H. Smith, Robert Callahan
  • Nucleotide and deduced amino acid sequences of tumor gene Int6
    Publication number: 20030044419
    Abstract: The present invention discloses the isolation of the human and murine wild-type Int6 gene and the cDNAs corresponding to these genes. The invention further describes the use of reagents derived from the nucleic acid and amino acid sequences of the Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines.
    Type: Application
    Filed: May 14, 2001
    Publication date: March 6, 2003
    Applicant: Government of the United States of America
    Inventors: Antonio Marchetti, Fiamma Buttitta, Gilbert H. Smith, Robert Callahan
  • Nucleotide and deduced amino acid sequences of tumor gene Int6
    Patent number: 6342392
    Abstract: The present invention discloses the isolation of the human and murine wild-type Int6 gene and the cDNAs corresponding to these genes.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: January 29, 2002
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Antonio Marchetti, Fiamma Buttitta, Gilbert H. Smith, Robert Callahan
  • Nucleotide and deduced amino acid sequences of tumor gene Int6
    Patent number: 6255105
    Abstract: The present invention discloses the isolation of the human and murine wild-type Int6 gene and the cDNAs corresponding to these genes. The invention further describes the use of reagents derived from the nucleic acid and amino acid sequences of the Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines.
    Type: Grant
    Filed: September 25, 1997
    Date of Patent: July 3, 2001
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Antonio Marchetti, Fiamma Buttitta, Gilbert H. Smith, Robert Callahan